Literature DB >> 8331227

Non-Hodgkin lymphoma of the central skull base: MR manifestations.

M H Han1, K H Chang, I O Kim, D K Kim, M C Han.   

Abstract

OBJECTIVE: The aim of this study was to demonstrate the MR characteristics of non-Hodgkin lymphoma of the skull base to help in the differential diagnosis of this neoplasm from other conditions.
MATERIALS AND METHODS: MR of five patients, 7-64 years old, with pathologically proved lymphomas of the skull base were reviewed. Three cases had primary skull base lesions involving the sphenoid bone and the cavernous sinus. One case with a nasal cavity lesion involving the skull base and one with a relapsing skull base lesion of previously treated tonsillar lymphoma were included.
RESULTS: The lesions had signal intensities that were similar to that of gray matter of brain on both T1- and T2-weighted imaging. Bilateral cavernous sinuses were involved with encasement of internal carotid arteries in every case. Postcontrast MR showed homogeneous enhancement of the tumor with dural infiltration along the planum sphenoidale, clivus, or tentorium. The clivus was destroyed or replaced by tumors in adult cases but in two children the clivus was preserved with intact sphenooccipital synchondrosis. In one case the tumor extended to the extracranial portion through the jugular foramen.
CONCLUSION: The MR findings of a permeative lesion of the skull base, invasion of the cavernous sinus without arterial narrowing, infiltration along the dural surface, and an iso- or hypointensity with brain on T2-weighted imaging should suggest lymphoma.

Entities:  

Mesh:

Year:  1993        PMID: 8331227     DOI: 10.1097/00004728-199307000-00009

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  10 in total

1.  An atypical cause of trigeminal neuralgia and panhypopituitarism.

Authors:  I Coulter; S Garrioch; A Toft
Journal:  Br J Radiol       Date:  2010-12       Impact factor: 3.039

2.  Burkitt's lymphoma of the skull base presenting as cavernous sinus syndrome in early childhood.

Authors:  P Kalina; K Black; R Woldenberg
Journal:  Pediatr Radiol       Date:  1996

3.  Cavernous Sinus: A Comprehensive Review of its Anatomy, Pathologic Conditions, and Imaging Features.

Authors:  A A Bakan; A Alkan; S Kurtcan; A Aralaşmak; S Tokdemir; E Mehdi; H Özdemir
Journal:  Clin Neuroradiol       Date:  2014-11-20       Impact factor: 3.649

4.  MRI of diffuse large B-cell non-Hodgkin's lymphoma of the head and neck: comparison of Waldeyer's ring and sinonasal lymphoma.

Authors:  Ann D King; Benjamin King Hong Law; Wai Kiu Tang; Frankie Kwok Fai Mo; Radha Raghupathy; Kunwar S Bhatia; Kenny I K Lei
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

5.  Central nervous system lymphoma presenting as trigeminal neuralgia: A diagnostic challenge.

Authors:  Jensen W J Ang; Arjun Khanna; Brian P Walcott; Kristopher T Kahle; Emad N Eskandar
Journal:  J Clin Neurosci       Date:  2015-04-10       Impact factor: 1.961

6.  Primary lymphoma of the skull base.

Authors:  F J Hans; M H T Reinges; K Nolte; P Reipke; T Krings
Journal:  Neuroradiology       Date:  2005-06-07       Impact factor: 2.804

7.  Sinonasal Non-Hodgkin's Lymphoma with Skull Base Involvement.

Authors:  A O Dare; R V Datta; T R Loree; W L Hicks; W Grand
Journal:  Skull Base       Date:  2001-05

8.  Central skull base lymphoma in children: MR and CT features.

Authors:  Hei-Kyung Choi; Jung-Eun Cheon; In-One Kim; Byung Jae Youn; Ah Young Jung; Su-Mi Shin; Woo Sun Kim; Kyung Mo Yeon
Journal:  Pediatr Radiol       Date:  2008-06-17

9.  Resolution of immune thrombocytopenic purpura associated with extranodal B-cell lymphoma of the petroclival region after radiotherapy.

Authors:  Takashi Watanabe; Hideyuki Kurihara; Satoshi Magarisawa; Shigeru Shimoda; Katsue Yoshida; Shogo Ishiuchi
Journal:  Surg Neurol Int       Date:  2010-11-27

10.  Long-term survival of diffuse large B cell lymphoma of the trigeminal region extending to the Meckel's cave treated by CHASER therapy: case report.

Authors:  Toshihide Tanaka; Naoki Kato; Kuniaki Itoh; Yuzuru Hasegawa
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-12-05       Impact factor: 1.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.